Fish Farming Companies Account for Over 80% Demand of Autogenous Vaccines for Aquaculture: Persistence Market Research

Fish Farming Companies Account for Over 80% Demand of Autogenous Vaccines for Aquaculture: Persistence Market Research

PR Newswire

NEW YORK, Feb. 12, 2021

NEW YORK, Feb. 12, 2021 /PRNewswire/ -- Fish is a widely consumed food across the world. In 2019, 177.8 million metric tons of fish were produced globally. In spite of such huge production in aquaculture, bacterial disease is a major issue, and is causing multibillion-dollar losses annually. In developing countries, fish diseases often spread quickly between small-scale aquaculture farms. Rising prevalence of infectious diseases such as bacterial diseases, viral diseases, and parasitic and fungal diseases amongst fish species remains a global issue for fish farmers.

Persistence Market Research Logo

Autogenous vaccines have been playing a vital role in bacterial disease control in aquaculture. This is the most effective method for preventing a wide range of bacterial and viral diseases. Autogenous vaccines are widely accepted by aquaculture farming companies during emergency outbreaks, due to very few commercial vaccines being available for specific aquaculture-related diseases.

According to the latest report published by Persistence Market Research, the global autogenous vaccine for aquaculture market was valued at US$ 11 Mn in 2020, and is expected to witness a CAGR of 5.5% during the forecast period (2020 – 2030).

Key Takeaways from Autogenous Vaccine for Aquaculture Market Study

Get the Sample PDF of the Report:

"Rise in prevalence of infectious diseases and demand for autogenous vaccines for preventive treatment will boost sales of autogenous vaccines for aquaculture over the coming years," says an analyst at Persistence Market Research.

Get Full Access of Report:

Collaborations & Acquisitions Key Strategy amongst Market Players

Leading players in the autogenous vaccine for aquaculture market are strengthening their product portfolios through acquisitions and expanding their regional presence.

Various players in the autogenous vaccine for aquaculture market are focusing on growth strategies such as collaboration and agreement licences.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the autogenous vaccine for aquaculture market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2020, on the basis of fish species (salmon, tilapia, bream, Labris Bergylta, Cyprinus Carpio, Sea Bass, Trout, and Cyclopterus Lumpus), pathogen type (bacteria and virus), and end user (fish farming companies and aquatic research institutes), across seven key regions of the world.

Browse Research Release at:

Browse End-to-end Market: Healthcare

Related Reports:

Autogenous Vaccines Market: 

Commercial Aquaculture Vaccines Market: aquaculture-vaccines-market.asp  

About Persistence Market Research 


Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At Persistence Market Research, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.


Rajendra Singh
Persistence Market Research
U.S. Sales Office:
305 Broadway, 7th Floor
New York City, NY 10007
United States
USA - Canada Toll-Free: 800-961-0353
Visit Our Website: 
Content Source:  


Voltar noticias em Inglês